|
|
|
Insider
Information: |
Sato Vicki L |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
1,670,897 |
|
Indirect Shares
|
8,084 |
|
|
Direct
Value |
$40,918,225 |
|
|
Indirect Value
|
$3,617,833 |
|
|
Total
Shares |
1,678,981 |
|
|
Total
Value |
$44,536,057 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
President |
2005-05-11 |
77,233 |
2005-05-11 |
8,084 |
Premium* |
|
Perkinelmer Inc |
PKI |
Director |
2017-02-09 |
29,970 |
2004-04-27 |
0 |
Premium* |
|
Infinity Pharmaceuticals Inc |
INFI |
Director |
2006-09-12 |
11,051 |
2006-09-12 |
0 |
Premium* |
|
Borgwarner Inc |
BWA |
Director |
2020-04-29 |
19,823 |
2014-04-30 |
0 |
Premium* |
|
Denali Therapeutics Inc. |
DNLI |
Director |
2024-05-15 |
116,369 |
2017-12-12 |
0 |
Premium* |
|
Vir Biotechnology, Inc. |
VIR |
Director |
2023-06-30 |
1,315,351 |
|
0 |
Premium* |
|
Allogene Therapeutics, Inc. |
ALLO |
|
2023-06-13 |
101,100 |
2021-07-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
227 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 10
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-01-14 |
4 |
AS |
$9.62 |
$36,556 |
D/D |
(3,800) |
116,917 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-01-21 |
4 |
AS |
$9.98 |
$37,924 |
D/D |
(3,800) |
113,117 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-01-28 |
4 |
AS |
$10.08 |
$38,304 |
D/D |
(3,800) |
109,317 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-02-04 |
4 |
AS |
$9.60 |
$36,480 |
D/D |
(3,800) |
105,517 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-02-11 |
4 |
AS |
$10.11 |
$38,418 |
D/D |
(3,800) |
101,717 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-02-18 |
4 |
AS |
$11.05 |
$41,990 |
D/D |
(3,800) |
100,608 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-02-25 |
4 |
AS |
$11.12 |
$42,256 |
D/D |
(3,800) |
107,733 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-03-03 |
4 |
AS |
$10.95 |
$41,610 |
D/D |
(3,800) |
100,608 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-03-10 |
4 |
AS |
$10.70 |
$40,660 |
D/D |
(3,800) |
100,608 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-03-17 |
4 |
AS |
$9.76 |
$37,088 |
D/D |
(3,800) |
100,608 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-03-24 |
4 |
AS |
$8.97 |
$34,086 |
D/D |
(3,800) |
100,608 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-03-31 |
4 |
AS |
$9.41 |
$35,758 |
D/D |
(3,800) |
100,608 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-04-07 |
4 |
AS |
$9.39 |
$65,730 |
D/D |
(7,000) |
100,608 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-04-14 |
4 |
AS |
$9.23 |
$64,610 |
D/D |
(7,000) |
100,608 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-04-21 |
4 |
AS |
$8.95 |
$62,650 |
D/D |
(7,000) |
100,608 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-04-28 |
4 |
AS |
$9.24 |
$64,680 |
D/D |
(7,000) |
100,608 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-05-05 |
4 |
AS |
$9.30 |
$65,100 |
D/D |
(7,000) |
100,608 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-05-12 |
4 |
AS |
$8.45 |
$59,150 |
D/D |
(7,000) |
188,108 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-05-19 |
4 |
AS |
$8.42 |
$58,940 |
D/D |
(7,000) |
188,108 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-05-26 |
4 |
AS |
$8.64 |
$60,480 |
D/D |
(7,000) |
188,108 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-06-02 |
4 |
AS |
$9.13 |
$63,910 |
D/D |
(7,000) |
188,108 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-06-09 |
4 |
AS |
$9.13 |
$63,910 |
D/D |
(7,000) |
188,108 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-06-16 |
4 |
AS |
$9.53 |
$66,710 |
D/D |
(7,000) |
188,108 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-06-23 |
4 |
AS |
$10.27 |
$71,890 |
D/D |
(7,000) |
188,108 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-06-30 |
4 |
AS |
$10.84 |
$75,880 |
D/D |
(7,000) |
188,108 |
|
- |
|
227 Records found
|
|
Page 3 of 10 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|